A pediatric trial of radiation/cetuximab followed by irinotecan/cetuximab in newly diagnosed diffuse pontine gliomas and high-grade astrocytomas: A Pediatric Oncology Experimental Therapeutics Investigators' Consortium study.

导出 OA

翻译打印收藏纠错

作者： Margaret E,Macy ^[1] ; Mark W,Kieran ^[2] ; Susan N,Chi ^[2] ; Kenneth J,Cohen ^[3] ; Tobey J,MacDonald ^[4] ; Amy A,Smith ^[5] ; Michael M,Etzl ^[6] ; Michele C,Kuei ^[7] ; Andrew M,Donson ^[7] ; Lia,Gore ^[1] ; Jennifer,DiRenzo ^[8] ; Tanya M,Trippett ^[8] ; Irina,Ostrovnaya ^[8] ; Aru,Narendran ^[9] ; Nicholas K,Foreman ^[1] ; Ira J,Dunkel ^[8]

作者单位： Department of Pediatrics, University of Colorado School of Medicine/Children's Hospital Colorado, Aurora, Colorado. ^[1] Pediatric Neuro-Oncology, Dana Farber Cancer Institute, Boston, Massachusetts. ^[2] Department of Pediatrics and Oncology, Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, Maryland. ^[3] Department of Pediatrics, Children's Healthcare of Atlanta/Emory University School of Medicine, Atlanta, Georgia. ^[4] Arnold Palmer Hospital for Children, Orlando, Florida. ^[5] Phoenix Children's Hospital, Phoenix, Arizona. ^[6] Department of Pediatrics, University of Colorado School of Medicine, Aurora, Colorado. ^[7] Department of Pediatrics, Memorial Sloan Kettering Cancer Center, New York, New York. ^[8] Department of Pediatrics and Oncology, Alberta Children's Hospital, Calgary, Canada. ^[9]

关键词 cetuximab chemotherapy diffuse intrinsic pontine glioma pediatric high-grade astrocytoma radiation